FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: ADVISORY COMMITTEE; OBSTETRICS, REPRODUCTIVE AND UROLOGIC DRUGS ADVISORY COMMITTEE; RENEWAL

WASHINGTON, March 18 -- Food and Drug Administration has issued a notice called: Advisory Committee; Obstetrics, Reproductive and Urologic Drugs Advisory Committee; Renewal.

The notice was published in the Federal Register on March 18 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.

Summary: The Food and Drug Administration (FDA) is announcing the renewal of the Obstetrics, Reproductive and Urologic Drugs Advisory Committee by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the Obstetrics, Reproductive and Urologic Drugs Advisory Committee for an additional 2 years beyond the charter expiration date. The new charter...